Fig. 2From: Mesenchymal stromal cells (MSCs) and their exosome in acute liver failure (ALF): a comprehensive reviewClinical trials based on mesenchymal stromal cells (MSCs) therapy in liver-associated conditions registered in ClinicalTrials.gov (November 2021). The schematic demonstrates clinical depending on the study phase (A), study status (B), MSCs source (C), study location (D), participant number (E), and condition (F)Back to article page